VRCI Recent activities 11/10/2014 17:13:55 $VRCI yep, it

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
VRCI Recent activities 11/10/2014 17:13:55 $VRCI
yep, it is there now. It must have been added late this afternoon. They should have put it there first
news looks there to me. loading zone for 2015 imo. more i read more i like VRCI$ Got a starter last week at 006 ready to add. this is going up. ready to wait i'm fairly convinced this will see .20 -.40 next year if things play out who knows. SS me likey!

imo -gl
Definitely covered that. $VRCI
The screening tests
today's news is on the website. which news are you referring to?
The fact that that news was never posted to their website does not add any credibility to it. People double-check the compagnies website to make sure the news are legit...
imo, that new is fake
Looks like today's $VRCI news addresses this major issue:

http://www.nytimes.com/2014/11/05/business/eb....html?_r=1
Great loading opportunity! $VRCI
Gotta love the gaps, but they always get filled. Time to move back up! $VRCI
JohnnyBlaze....Float is tiny! I THINK NOT!!! If you were told it's 30 million BS!!
yep, the all important gap fill completed.
thank you for update/ vrci
This will re-test .01 again, only a matter of time
It traded at .10 this year if I'm not mistaken
Let the small flippers flip. This is a huge stock for a longer hold.. You will see the test of .10.15 cents in the near future.
EXactly! Good find EMPTY BONES
This one is fun to short at the right moment if shares are available. It's almost always guaranteed that with every artificial pump, this thing will get crapped all over.

I'm on the long side personally because I feel it will have some more bounces before it flat lines, but it's a very dangerous trade since this thing is illiquid as $&@!
Terrible performance
Usually the bounces here only last an hour or two before the stock returns to its .005-.006 position, but it's holding at higher levels every single time it drops back down. It just gets harder to get above .01 on a bounce because more people try to flip this every time shares are dumped all over the bid. I guess I'm guilty of that too, but at least I tell the truth about it and don't pump this POS with repetitive post about the moon and this will explode.

Last time I put that much cash into such an illiquid stock. 1.8 mil position left, I can't wait to get rid of my remaining shares. I guess I should be thanking the people that pump this, they are the only ones creating a market.

I find it funny how people know when news is going to come out, without actually saying it, yet being able to flood the board the night before in anticipation. I have a feeling the company has minions on this board helping them dilute on every fluff news release. These are all my opinions though, but seems illegal to me!
NEWS RELEASE VERDE SCIENCE PURSUING DEVELOPMENT OF PROMISING POINT-OF-CARE EBOLA SCREENING TEST Richmond, BC, Nov 10, 2014. "InvestorsHub NewsWire" - 11/10/2014 9:00:00 AM
VERDE SCIENCE AND STERKEM GROUP SIGN PHARMACEUTICAL DEVELOPMENT AGREEMENT "InvestorsHub NewsWire" - 11/6/2014 8:00:00 AM
NEWS RELEASE VERDE SCIENCE R&D TEAM READY TO MOVE FORWARD WITH DESIGN OF RESEARCH PLAN "InvestorsHub NewsWire" - 11/4/2014 8:00:00 AM
Verde Science Appoints Chief Technology Officer "InvestorsHub NewsWire" - 10/22/2014 9:00:00 AM
StocksImpossible.com announces one of their biggest stock alerts of the fall coming Tuesday October 7th, 2014 at market open. "InvestorsHub NewsWire" - 10/6/2014 9:32:51 AM
VERDE SCIENCE STRENGTHENS SCIENTIFIC TEAM "InvestorsHub NewsWire" - 10/2/2014 9:00:00 AM
ID Global Corporation Seeks Strategic Partnership with Verde Science, Inc. "PR Newswire (US)" - 10/1/2014 10:47:00 AM
Verde Science forms R and D Alliance "InvestorsHub NewsWire" - 9/23/2014 11:39:34 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 9/17/2014 1:48:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/17/2014 6:00:01 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/12/2014 1:17:14 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2014 6:00:37 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/27/2014 12:00:49 PM
Verde Science, Inc. Announces the Appointment of Mr. Bradley J. Dixon, J.D. to the Board of Directors "Marketwired" - 6/18/2014 2:36:21 PM
Verde Science, Inc. Announces Appointment of Mr. Ken Berscht as Chief Executive Officer "Marketwired" - 6/16/2014 9:00:00 AM
Verde Science Announces Paul Pelosi Interview at Cambridge House Conference and Medical Marijuana Article Coverage "Marketwired" - 6/6/2014 9:00:00 AM
Investing in the Budding Tesla of Medical Marijuana "GlobeNewswire Inc." - 6/2/2014 9:58:17 AM
Verde Science, Inc. Signs First Long Term Advisory Services Contract With Los Angeles County Medical Marijuana Dispensary; Un... "Marketwired" - 6/2/2014 6:00:00 AM
Verde Science Announces the Appointment of Paul Pelosi, Jr. to Its Advisory Board "Marketwired" - 5/22/2014 9:00:00 AM
Verde Science, Inc. Announces New Strategic Direction That Focuses on Providing Innovative Advisory Services Designed to Incr... "Marketwired" - 5/20/2014 1:05:05 PM
Verde Science, Inc. Announces Appointment of Medical Marijuana Industry Veteran to Board of Directors "Marketwired" - 5/14/2014 9:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 4/28/2014 3:33:42 PM
Rango Energy, Soon to Become Verde Science, Inc. Provides Update on Entry Into Medical Marijuana Business Sector "Marketwired" - 4/16/2014 4:24:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/15/2014 5:21:00 PM
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading